MedTrace Logo

A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants

NCT03936374 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2019-09-23

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of multiple dose administrations of Omeprazole on the pharmacokinetics of BMS-986205.

Conditions

  • Healthy

Interventions

DRUG

BMS-986205

Participants will receive BMS-986205 on Days 1 and 15

DRUG

omeprazole

Participants will receive omeprazole on Days 10 to 15

Sponsors & Collaborators

Principal Investigators

  • Antonia Davidson, MD · PPD Development, LP

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-08
Primary Completion
2019-07-20
Completion
2019-07-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03936374 on ClinicalTrials.gov